One member of a larger family of oxygen sensing enzymes could offer a viable target for triple negative breast cancer (TNBC), researchers report in a new study. The findings might offer hope to this subset of patients who have few effective treatment options and often face a poor prognosis.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023